A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism

被引:44
作者
Camacho, P
Gordon, D
Chiefari, E
Yong, S
DeJong, S
Pitale, S
Russo, D
Filetti, S
机构
[1] Loyola Univ, Med Ctr, Div Endocrinol & Metab, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
[3] Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA
[4] Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Cattedra Endocrinol, Catanzaro, Italy
[5] Univ Catanzaro, Dipartimento Sci Farmacobiol, Catanzaro, Italy
关键词
D O I
10.1089/thy.2000.10.1009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hot nodules are rarely found to be carcinomas. We report a case of a nonmetastatic follicular carcinoma that presented as a hot nodule that was causing hyperthyroidism. A base substitution (ATC for TTC) was found in codon 486 of the TSH receptor gene and this resulted in the substitution of an isoleucine for a phenylalanine in the first extracellular loop of the receptor. This was absent in the deoxyribonucleic acid from the surrounding normal thyroid tissue indicating its somatic origin. This mutation, which was previously reported to activate both cyclic adenosine monophosphate and the inositol phosphate-diacylglycerol cascades, may have been responsible for the constitutive activation of the thyrotropin receptor and resulting hyperfunction of this follicular carcinoma.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 23 条
  • [1] Hyperfunctioning differentiated thyroid carcinoma
    Appetecchia, M
    Ducci, M
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (03) : 189 - 192
  • [2] Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features
    Arturi, F
    Capula, C
    Chiefari, E
    Filetti, S
    Russo, D
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (03) : 234 - 236
  • [3] Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule
    Cirillo, RL
    Pozderac, RV
    Caniano, DA
    Falko, JM
    [J]. CLINICAL NUCLEAR MEDICINE, 1998, 23 (06) : 345 - 349
  • [4] Constitutive activation of the G(s)alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas
    Derwahl, M
    Hamacher, C
    Russo, D
    Broecker, M
    Manole, D
    Schatz, H
    Kopp, P
    Filetti, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) : 1898 - 1904
  • [6] Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells
    Fournes, B
    Monier, R
    Michiels, F
    Milgrom, E
    Misrahi, M
    Feunteun, J
    [J]. ONCOGENE, 1998, 16 (08) : 985 - 990
  • [7] Contrasting effects of activating mutations of GαS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells
    Ludgate, M
    Gire, V
    Crisp, M
    Ajjan, R
    Weetman, A
    Ivan, M
    Wynford-Thomas, D
    [J]. ONCOGENE, 1999, 18 (34) : 4798 - 4807
  • [8] MICHIGISHI T, 1992, J NUCL MED, V33, P2024
  • [9] MOLECULAR-CLONING, SEQUENCE AND FUNCTIONAL EXPRESSION OF THE CDNA FOR THE HUMAN THYROTROPIN RECEPTOR
    NAGAYAMA, Y
    KAUFMAN, KD
    SETO, P
    RAPOPORT, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) : 1184 - 1190
  • [10] SOMATIC MUTATIONS CAUSING CONSTITUTIVE ACTIVITY OF THE THYROTROPIN RECEPTOR ARE THE MAJOR CAUSE OF HYPERFUNCTIONING THYROID ADENOMAS - IDENTIFICATION OF ADDITIONAL MUTATIONS ACTIVATING BOTH THE CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE AND INOSITOL PHOSPHATE-CA2+ CASCADES
    PARMA, J
    VANSANDE, J
    SWILLENS, S
    TONACCHERA, M
    DUMONT, J
    VASSART, G
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (06) : 725 - 733